体内CAR-T:全球竞赛已打响 关注云顶新耀和石药集团

华福证券有限责...
23 Jun

专题:体内CAR-T一旦被证明安全、有效,将带来细胞治疗范式的转变,海外Capstan Therapeutics 、EsoBiotec、 Umoja等Biotech已有产品启动临床1期,25年H2有望有初步疗效验证数据读出。艾伯维、阿斯利康等多个制药巨头已通过合作/收购布局体内CAR-T赛道。国内企业中云顶新耀mRNA自体生成CAR-T项目已取得多项临床前验证,在人源化小鼠肿瘤模型中实现了有效...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10